|
Speakers & Topics
Neurodegenerative Diseases
Elena Cattaneo, PhD, University of Milan, Italy
Steven Goldman, MD, PhD, University of Rochester, USA
Hideyuki Okano, MD, PhD, Keio University, Japan
Lorenz Studer, MD, Memorial Sloan Kettering Cancer Center, USA
Leslie Thompson, PhD, University of California Irvine, USA
Vision Loss
Kapil Bharti, PhD, National Institutes of Health, USA
Erin Kimbrel, PhD, Astellas Pharma, USA
Rachael Pearson, PhD, University College London, UK
Graziella Pellegrini, PhD, University of Modena and Reggio Emilia, Italy
Diabetes
Kevin D’Amour, PhD, Viacyte, USA
Felicia Pagliuca, PhD, Semma Therapeutics, USA
Cardiovascular Disease
Mauro Giacca, MD, PhD, ICGEB, Italy
Michael Laflamme, MD, PhD, UHN, University of Toronto, Canada
Charles Murry, MD, PhD, University of Washington, USA
Immunotherapy
Harry Atkins, MD, FRCPC, Ottawa Hospital Research Institute, Canada
Michel Sadelain, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
Dan Shoemaker, PhD, Fate Therapeutics, USA
Escaping the Immune System
David Russell, MD, PhD, University of Washington & Universal Cells Inc., USA
Sonja Schrepfer, MD, PhD, University of California San Francisco, USA
Diverse Applications
Lynn Allen-Hoffmann, PhD, University of Wisconsin-Madison & Stratatech, USA
Regulatory Challenges Panel
Joy Cavagnaro, PhD, Access BIO, USA
Erin Kimbrel, PhD, Astellas Pharma, USA
Doug Sipp, BA, Riken, Japan
|
